Cargando…
Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
Chemotherapy induced infertility is a problem which is growing and often neglected. Fertility preservation strategy is an important component of the management in young patients with cancer. Gonadotropin releasing hormone analog therapy helps in ovarian suppression and the evidence is inconclusive f...
Autores principales: | Kumar, K. V. S. Hari, Shaikh, Altamash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830377/ https://www.ncbi.nlm.nih.gov/pubmed/24251230 http://dx.doi.org/10.4103/2230-8210.119514 |
Ejemplares similares
-
Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
por: Wang, Chuan, et al.
Publicado: (2013) -
Fertility Preservation Options After Gonadotoxic Chemotherapy
por: Hyman, Jordana Hadassah, et al.
Publicado: (2013) -
Male fertility preservation before gonadotoxic therapies
por: Wyns, C.
Publicado: (2010) -
The role of gonadotropin-releasing hormone agonists in female fertility preservation
por: Lee, Jae Hoon, et al.
Publicado: (2021) -
Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy
por: Massarotti, C., et al.
Publicado: (2023)